Full Panel Blood Analysis
A comprehensive laboratory evaluation covering more than 100 biomarkers, ordered and interpreted by Yuleisy Coto, MSN, APRN, FNP-C. The purpose is to identify what is actually driving your symptoms before any intervention is recommended.
Full panel blood analysis at Cobblestone Spine and Joint Institute is a comprehensive laboratory evaluation ordered and interpreted by Yuleisy Coto, MSN, APRN, FNP-C (FL APRN License No. APRN11009024). The panel is not a routine checkup CBC. It covers more than 100 biomarkers across metabolic function, hormone levels, inflammatory markers, nutrient status, thyroid function, and cardiovascular risk indicators. The purpose is to identify the biochemical conditions that are driving a patient's symptoms before recommending any intervention.
Most patients who come to Cobblestone for blood analysis have already had standard labs ordered by a primary care provider and been told everything looks normal. Normal on a standard metabolic panel means within the population reference range, which is a statistical construct based on the distribution of values in a general population that includes a large proportion of metabolically unhealthy people. The functional medicine reference ranges Yuleisy Coto uses are narrower and more clinically meaningful. A TSH of 3.8 is within the standard lab reference range of 0.4 to 4.5 but is well above the functional range of 1.0 to 2.0 where thyroid function is optimal. That distinction changes the clinical picture.
Schedule a Consultation
Royal Palm Beach, FL 33411
| Monday | 9:00 AM – 7:00 PM |
| Tuesday | 3:00 PM – 7:00 PM |
| Wednesday | 9:00 AM – 7:00 PM |
| Thursday | Closed |
| Friday | 9:00 AM – 7:00 PM |
| Saturday | 9:00 AM – 12:00 PM |
| Sunday | Closed |
Related Services
- Hormone Replacement Therapy
- Peptide Therapy
- Medical Weight Management
- Regenerative Medicine
Related Conditions
What the Panel Covers
The complete panel includes a comprehensive metabolic panel, complete blood count with differential, full thyroid panel (TSH, Free T3, Free T4, Reverse T3, thyroid antibodies), sex hormone panel (testosterone total and free, SHBG, estradiol, progesterone, DHEA-S, LH, FSH), adrenal markers (cortisol, DHEA), inflammatory markers (hs-CRP, homocysteine, fibrinogen, ferritin), insulin and fasting glucose with HOMA-IR calculation, a full lipid panel with fractionation, vitamin D (25-OH), B12 and folate, iron studies, magnesium, and zinc. For patients on hormone replacement therapy or peptide protocols, additional markers are added based on what is being monitored.
The panel is drawn at a local lab. Results are typically available within two to three business days. Yuleisy Coto then conducts a counseling appointment to review every finding in the context of your symptoms, history, and goals. This is not a brief overview. It is a detailed discussion of what each result means, how the results interact with each other, and what the clinical response should be.
Who Benefits Most
Patients who are experiencing fatigue, unexplained weight changes, mood disruption, cognitive fog, poor recovery from exercise, or declining performance without a clear cause are the primary candidates. These symptoms are frequently attributed to stress, poor sleep, or aging by standard medical evaluation. In many cases, the actual cause is a measurable biochemical abnormality that shows up on a full panel but not on a standard panel.
Patients who are starting or monitoring hormone replacement therapy require baseline and follow-up lab work as a non-negotiable component of safe management. Patients on peptide therapy protocols, particularly growth hormone secretagogues, benefit from baseline IGF-1, fasting glucose, and insulin measurements. Medical weight management patients receive a metabolic baseline that includes insulin resistance markers, thyroid function, and inflammatory status before the program begins.
Counseling and Follow-Up
The lab results appointment is included. Yuleisy Coto does not hand you a printout and tell you to follow up with your doctor. He reviews every finding with you, explains the clinical significance, and maps out a specific response based on what the results show. If the findings indicate a condition outside the scope of what Cobblestone manages, he refers you to the appropriate specialist with a clear summary of what was found and why it matters.
Follow-up panels are ordered at clinically appropriate intervals based on what is being monitored and what interventions have been initiated. For patients on hormone or peptide protocols, monitoring panels are typically ordered at 6 and 12 weeks after initiation, then quarterly.